Search

Your search keyword '"Mike Kulis"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Mike Kulis" Remove constraint Author: "Mike Kulis"
66 results on '"Mike Kulis"'

Search Results

2. Tick salivary gland extract induces alpha‐gal syndrome in alpha‐gal deficient mice

3. Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy

4. Tick salivary gland extract induces alpha‐gal syndrome in alpha‐gal deficient mice

5. Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research

6. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study

7. Content and performance of the MiniMUGA genotyping array, a new tool to improve rigor and reproducibility in mouse research

9. Characterization of the B-cell receptor repertoires in peanut allergic subjects undergoing oral immunotherapy

10. Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab

11. Hypoallergenic Proteins for the Treatment of Food Allergy

12. Food antigen sensitization in genetically-susceptible mice is influenced by fecal IgA, antigen absorption, and gut microbiome composition

13. Mast cell desensitization inhibits calcium flux and aberrantly remodels actin

14. Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness

15. Utility of component analyses in subjects undergoing sublingual immunotherapy for peanut allergy

16. Antigenic Liposomes for Generation of Disease-specific Antibodies

17. Tree nut allergies: Allergen homology, cross-reactivity, and implications for therapy

18. Diagnosis, Management, and Investigational Therapies for Food Allergies

19. Peanut Allergy: New Developments and Clinical Implications

20. Peanut allergen Ara h 2-specific T cells are activated via Ras-Erk MAP kinase pathway signalling and identified by CD154 expression

21. Single–tree nut immunotherapy attenuates allergic reactions in mice with hypersensitivity to multiple tree nuts

22. Pioneering immunotherapy for food allergy: clinical outcomes and modulation of the immune response

24. Intragastric sensitization to peanut in the absence of a Th2-skewing adjuvant in mice genetically predisposed to food allergy

25. Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2

26. Diacylglycerol kinase ζ deficiency in a non-CD4+ T-cell compartment leads to increased peanut hypersensitivity

27. Novel strategy to create hypoallergenic peanut protein-polyphenol edible matrices for oral immunotherapy

29. Carrying peptides towards the ideal allergen-specific immunotherapy

30. Pepsinized cashew proteins are hypoallergenic and immunogenic and provide effective immunotherapy in mice with cashew allergy

31. Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice

32. Oral immunotherapy for food allergy: clinical and preclinical studies

33. A randomized controlled study of peanut oral immunotherapy (OIT): clinical desensitization and modulation of the allergic response

34. Food allergies and hypersensitivity: a review of pharmacotherapy and therapeutic strategies

35. Peanut Oral Immunotherapy and Omalizumab Treatment for Peanut Allergy

37. Nasal Immunization with Peanut Antigen and The Cationic Peptide Adjuvant Mastoparan 7 Induces Serum Humoral Immunity That Protects Peanut Allergic Mice Against Systemic Anaphylaxis

41. Comparison of Sublingual Immunotherapy (SLIT) versus Oral Immunotherapy (OIT) in the Treatment of Peanut Allergy

49. Double-Blinded Placebo Controlled Sublingual Immunotherapy (SLIT) Trial for Peanut Allergy

Catalog

Books, media, physical & digital resources